Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.
Audran R, Chtioui H, Thierry AC, Mayor CE, Vallotton L, Dao K, Rothuizen LE, Maghraoui A, Pennella EJ, Brunner-Ferber F, Buclin T, Spertini F.
Audran R, et al. Among authors: maghraoui a.
Sci Rep. 2024 Jun 4;14(1):12872. doi: 10.1038/s41598-024-61265-2.
Sci Rep. 2024.
PMID: 38834577
Free PMC article.
Clinical Trial.